Maverick Medical AI has announced the successful deployment of its real-time, AI-powered autonomous medical coding solution at all 399 RadNet, Inc. (NASDAQ: RDNT) locations. RadNet is a national leader in delivering high-quality, cost-effective outpatient diagnostic imaging services. RadNet has successfully…
Life Healthcare delivered a strong performance in the second half of 2024, particularly in its acute and complementary healthcare businesses in southern Africa. Acute hospital patient volumes showed positive growth, with paid patient days (PPDs) increasing by 1.6%. Occupancy rates…
Sickday Medical House Calls, the largest and longest-serving medical house call practice in New York City, is reshaping the way travelers experience healthcare. For nearly two decades, Sickday has been providing on-demand, high-quality medical care to visitors in the city,…
DeepHealth, Inc., a subsidiary of RadNet, Inc. (NASDAQ: RDNT), has received expanded FDA 510(k) clearance for its groundbreaking mammography software, SmartMammo™. The enhanced clearance, announced recently, allows SmartMammo Dx, an AI algorithm, to be compatible with GE HealthCare’s Senographe Pristina™…
Teladoc Health has introduced a groundbreaking technology that combines artificial intelligence (AI) and real-time monitoring to enhance patient safety in hospitals. This innovative solution, known as Virtual Sitter, is designed to help hospital staff detect when a patient is at…
In observance of World AIDS Day (WAD) 2024 on December 1, AHF UK will host a commemorative event on Monday, December 2, 2024, from 9:30 a.m. to 3:00 p.m. at Croydon University Hospital (530 London Road, Thornton Heath, Surrey, CR7…
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a global leader in precision genetic medicine for rare diseases, announced on November 29, 2024, the granting of equity awards to 14 new employees who joined the company in November 2024. These equity awards, which…
The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), has announced its first round of grant recipients for The Cigna Group Health Equity Impact Fund. This initiative will distribute $9 million over the next three years…
AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, has announced that the U.S. Food and Drug Administration (FDA) has approved Rapiblyk™ (landiolol) for the treatment of supraventricular tachycardia (SVT), including atrial fibrillation and atrial flutter, in critical care…
Galderma recently announced that the full results from the Phase III OLYMPIA 1 trial, which evaluated the efficacy and safety of nemolizumab in adults with moderate-to-severe prurigo nodularis, were published in JAMA Dermatology. The data from this trial, in conjunction…